IFNB1 and neoplasm: Using oncolytic vesicular stomatitis virus that encodes murine IFN-β and the sodium iodide symporter (VSV-mIFNB-NIS) with anti-PD-L1 antibody in mice that had acute myeloid leukemia resulted in improved host anti-tumour response, increased survival of the mice, and increase in tumour-infiltrating T cells [103].